Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Cronos Group

Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demand

Beyond Canada, this global cannabis company is focused on its international business, particularly in Germany, Australia, and the UK.

Benzinga

2 Cannabis Stocks I Would Flat-Out Avoid In 2024, and One I Would Buy

The cannabis industry is expanding rapidly, but only a few cannabis companies can be winners.

Barchart

US to reclassify marijuana as less dangerous drug in historic shift

Shares of cannabis companies surge as much as 80 percent after move to classify drug as schedule three substance.

Al Jazeera

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Cannabis Stocks Analysts Like Better Than Canopy Growth

Discover three cannabis stocks with significant growth potential, and learn why analysts favor these names over Canopy Growth.

Barchart

3 Cannabis Stocks to Consider Buying as HHS Recommends Easing Restrictions on Marijuana

Cannabis stocks could deliver outsized gains if marijuana is rescheduled, per a recent HHS recommendation. While the DEA weighs its options, here's a look at three names with significant upside potential, according to analysts.

Barchart

Cronos Group (CRON) vs. ICL Group (ICL): Which Stocks Is a Better Buy?

The agriculture industry is poised for long-term growth, supported by the rapid adoption of agricultural mechanization and government support. While leading agriculture stocks Cronos Group (CRON) and ICL Group (ICL) should benefit from the industry tailwinds, let us determine which stock is the better buy.

StockNews.com

Should You Buy Shares of Cronos Group (CRON) in July?

Cannabis producer Cronos Group (CRON) is experiencing turbulent times with weakening sales and losses. So, will it be worth investing in the stock now? Read on.

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Cronos Group (CRON) vs. MariMed (MRMD): Which Stock Are Investors Buying?

With evolving food consumption trends, favorable government policies and funding, and the adoption of cutting-edge technologies, the agricultural industry is well-placed to experience significant growth in the long run. So, let’s compare prominent agriculture stocks Cronos Group (CRON) and MariMed (MRMD) to identify which is gaining immense popularity among investors.…

StockNews.com

Is Cronos Group (CRON) a Good Buy?

Despite the growing market for recreational cannabis, Cronos Group (CRON) has failed to surpass its consensus EPS and revenue estimates during the first quarter. However, given its substantial cash reserves and no long-term debt, is CRON a good buy now? Keep reading.

StockNews.com

Leading Cannabis Companies Launch 'Buy Legal' Campaign To Share Benefits Of Buying On Legal Market

Organized by the US Cannabis Council (USCC), the Buy Legal campaign is partnering with elected officials, cannabis companies, individuals and organizations to promote a safe, legal and well-regulated industry.

Benzinga

Global Cannabis Stock Index Meltdown in September, 'Didn't Matter Much,' Expert Says

In September, the Global Cannabis Stock Index closed low on 9/30 and ended the month down 25.9%, wrote Ala

Benzinga

Cronos Partners With Geocann To Launch CBD Gel Capsules By Lord Jones Utilizing VESIsorb For Faster Absorption

Cronos Group Inc. (NASDAQ: CRON) (TSX:CRON) launched the first of what is expected to be a range of products, in partnership with Geocann, which will utilize the VESIsorb delivery system.

Benzinga

Cronos Q1 Revenue Improves 101.61% YoY, Cannabis Company Attributes Growth To This

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) reported Tuesday its 2022 first quarter business results with net revenue growth of 101.61% year-over-year, due to the revenue improvements in the Israeli medical market and the Canadian adult-use market.

Benzinga

Cronos Group: Q1 Earnings Insights

Cronos Group (NASDAQ:CRON) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

A Preview Of Cronos Group's Earnings

Cronos Group (NASDAQ:CRON) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Cronos Group will report an earnings per share (EPS) of $-0.08.

Benzinga

These 7 Cannabis Stocks May Be Underappreciated As Market Continues To Rebound

Over the past couple of months, the cannabis sector has faced many challenges resulting in marijuana stocks dropping.

Benzinga

Here's Why Aurora Cannabis, Canopy Growth, Cronos Group, Sundial Growers And Tilray Shares Are Falling

Shares of many cannabis stocks, including Aurora Cannabis Inc (NASDAQ: ACB), Canopy Growth Corp (NASDAQ: CGC), Cronos Group Inc (NASDAQ:

Benzinga

Here's Why Aurora Cannabis, Canopy Growth, Cronos Group, Sundial Growers And Tilray Shares Are Rising

Shares of several cannabis stocks, including Aurora Cannabis Inc (NASDAQ: ACB), Canopy Growth Corp (NASDAQ: CGC), Cronos Group Inc (NASDAQ:

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Here's Why Aurora Cannabis, Canopy Growth, Cronos Group, Sundial Growers And Tilray Shares Are Popping Off

Shares of several cannabis stocks, including Aurora Cannabis Inc (NASDAQ: ACB), Canopy Growth Corp (NASDAQ: CGC), Cronos Group Inc (NASDAQ:

Benzinga

Cannabis Movers & Shakers: VerdePharmHealth, Wana Brands, TILT Holdings, Flora Growth, Trees Corporation, Cronos Group

As Benzinga Cannabis Capital Conference returns (April 20-21) in Miami, gathering top CEOs, investors and leaders in the cannabis industry, let's scroll through the latest leadership changes within the space.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 22, 2022

Upgrades

Benzinga

Analyst Ratings For Cronos Group

Cronos Group (NASDAQ:CRON) has observed the following analyst ratings within the last quarter:

Benzinga

Recap: Cronos Group Q4 Earnings

Cronos Group (NASDAQ:CRON) reported its Q4 earnings results on Tuesday, March 1, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Benzinga

Cronos Group Reports 59% YoY Revenue Increase In FY 2021, Plans To Exit Of Peace Naturals Campus In Stayner, ON

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) announced its 2021 fourth quarter and full-year business and financial results.

Benzinga

Thinking About Buying Stock In Pieris Pharmaceuticals, Baidu Or Cronos Group?

Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders. Analysts arrive at stock ratings by researching public financial statements, communicating with executives and customers and following industry trends.

1 2

People

Joe Biden

67,840 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.